Cargando…

Developing new treatments for breast cancer

Detalles Bibliográficos
Autor principal:	Lane, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300361/ http://dx.doi.org/10.1186/bcr820

Ejemplares similares

Development of CDK inhibitors as cancer therapeutics
por: Lane, D
Publicado: (2005)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Stem cells in human breast development and cancer
por: Wicha, M, et al.
Publicado: (2005)

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2008)

Minimising surgical treatment of early breast cancer
por: Rainsbury, R
Publicado: (2008)

Minimising oncological treatment of early breast cancer
por: Yarnold, J
Publicado: (2008)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk
por: Pinker, K, et al.
Publicado: (2010)

Translating breast cancer research into clinical practice — new approaches and better outcomes
por: Johnston, SRD
Publicado: (2006)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment
por: Hall, J, et al.
Publicado: (2000)

Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
por: Pusztai, L
Publicado: (2009)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Size matters: second breast cancer size following treatment for primary cancer as a predictor of survival
por: MacLennan, GS, et al.
Publicado: (2010)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Two molecular cytogenetic views of breast cancer
por: Gray, J, et al.
Publicado: (2000)

Breast interventional devices: how they evolve and define new subspecialities
por: Burbank, F
Publicado: (2006)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Clinical breast cancer and estrogen
por: Chew, HK
Publicado: (2003)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

O031 Nocturnal melatonin secretion in post-treatment breast cancer patients: a preliminary study
por: Subramanian, H, et al.
Publicado: (2021)

A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales
por: Fielder, HM, et al.
Publicado: (2004)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Developing a new brace with pressure measurements
por: Hermus, J, et al.
Publicado: (2009)

Multistatic radar: first trials of a new breast imaging modality
por: Shere, M, et al.
Publicado: (2009)

Interval cancer review in the Leicestershire symptomatic breast service
por: Tennant, SL, et al.
Publicado: (2009)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of response to endocrine treatment in breast cancer
por: Soon, YH, et al.
Publicado: (2015)

Chemoprevention for breast cancer: current status
por: Boyle, P
Publicado: (2004)

Promoting early presentation of breast cancer
por: Ramirez, AJ
Publicado: (2008)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mlpn1ebsvg6ldaabcvc1f8kmk8